Mice Model Technologies Market Poised for 7.4% CAGR Growth, Reaching USD 3.2 Bn by 2031 | Transparency Market Research – Yahoo Finance

Transparency Market Research

North America to provide significant mice model technologies market opportunities to regional and global manufacturers. High incidence of genetic disorders worldwide has led the significant Research and Development investment in genetic testing and a rise in the adoption of CRISPR technology in the healthcare industry.

Wilmington, Delaware, United States, May 16, 2023 (GLOBE NEWSWIRE) -- The global mice model technologies market stood at US$ 1.6 billion in 2022, and is projected to reach US$ 3.2 billion in 2031. The industry is anticipated to expand at a CAGR of 7.4% between 2023 and 2031.

Personalized medicines are highly preferred for treating many genetic diseases. Mice models help facilitate the development of personalized medicines. Humanized mice models are also gaining popularity in the study of personalized medicines. Especially in cancer research, personalized mice models can be created by implanting a piece of the patients tumor in the immune-compromised mice. Mice can then be tested for response to various personalized cancer drugs. Studies yield promising personalized drug therapies for cancer.

Get Sample PDF Copy of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84893

Pharmaceutical companies have also been reported to use mouse models derived from cancer cell lines to test and improve the effectiveness of new anticancer drugs. Rising demand for personalized medicines would thus drive the demand for mice models in research studies.

Recent mice model technologies market size trends indicate that with the introduction of emerging gene editing techniques particularly CRISPR/Cas9, companies have witnessed tremendous opportunities. Unmet need for efficacious therapeutics for infectious disease, diabetes, and oncology has spurred the commercialization of NOD SCID gamma mouse, found the TMR analysts. Emergence of mouse xenograft models for use in human cancer therapeutics research is a notable case in point, which will boost the future market outlook for mice model technologies.

Story continues

Significant decline in the application of the mice model in drug development apart from COVID-19 because many countries had been in lockdown and have suspended trade with other countries, implemented travel restrictions, etc., leading to declining in market capitalizations of major companies across the world, along with a decline in industrial production and pre-clinical trial which will negatively impact market growth.

Global Mice Model Technologies Market: Growth Drivers

Prevalence of chronic diseases is steering the need for advancing biomedical research strategies. Growing use of mice models in modeling human diseases is propelling strides in the mice model technologies market.

Advent of CRISPR-based techniques and a host of advanced molecular genome-altering technologies has created enormous opportunities. Techniques and technologies are successfully used for creating genetically engineered mouse models.

Expand Operations in the Future To Get Requisite Details, Ask for a Custom Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84893

Key Takeaways of Market Report

Global mice model technologies market to generate absolute dollar opportunity worth US$ 3.2 billion until 2031.

Global mice model technologies market from 2022 to 2031 is 7.4%

Global mice model technologies market is currently valued at US$ 1.69 billion in 2022.

Global mice model technologies market stood at US$ 1.6 billion in 2021.

Market value of the global mice model technologies market from 2018 to 2022 is 6.89%

North America is said to have a 6.2% market CAGR with the United States being subject to the adoption of mice model technologies at a higher rate.

The Asia-Pacific is expected to grow at a rapid rate of CAGR with 5.4% in the mice model technologies market going forward with China leading from the front.

North America is said to have a 40% market share being subject to the adoption of mice model technologies at a higher rate.

Global Mice Model Technologies Market: Regional Landscape

North America held a key share of the global mice model technologies market in 2021. Enormous research in gene editing technologies over the years and the adoption of new genetic engineering techniques notably CRISPR generated substantial revenue streams in the regional market.

Asia Pacific is estimate to be a lucrative market. Growth is fuelled by investments in biomedical research and drug discovery projects. Cutting-edge research in COVID-19 for the development of effective and safe vaccines and treatments opened up unprecedented opportunities for players in the Asia Pacific mice model technologies market.

Global Mice Model Technologies Market: Key Players

StrategiesGemPharmatech announced that it had entered into a strategic license agreement with Charles River Laboratories, Inc. for exclusive distribution of its next generation NOD CRISPR prkdc IL2r gamma (NCG) mouse lines in North America

AcquistionsCharles River Laboratories signed an agreement to breed, distribute, market, and sell Hera BioLabs SRG rat to the global preclinical research community. Unlike other immunodeficient model created through knockout mutations in the Rag2 and IL2R gamma genes that results in mature B, T, and NK, cell efficiencies.DevelopmentsCharles River Laboratories inked a licensing deal with Crown Bioscience, a drug discovery and development services provider, for expanded access to the Zucker Diabetic Sprague- Dawley (ZDSD) rat model

For In-Depth Competitive Analysis, Buy this Report Now@ https://www.transparencymarketresearch.com/checkout.php?rep_id=84893&ltype=S

Global Mice Model Technologies Market: Segmentation

Technology

CRISPR Knockout

CRISPR Knockin

Random Insertions

Large, Targeted Insertions

ES Cell Modification (Homologous Recombination)

Others

End-user

Pharmaceutical Companies

Biotechnology Companies

Academic and Research Facilities

Contract Research and Manufacturing Organizations

Regions

North America

Latin America

Europe

Asia Pacific

Middle East and Africa

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:Nikhil SawlaniTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website:https://www.transparencymarketresearch.com Blog:https://tmrblog.com Email:sales@transparencymarketresearch.com

The rest is here:
Mice Model Technologies Market Poised for 7.4% CAGR Growth, Reaching USD 3.2 Bn by 2031 | Transparency Market Research - Yahoo Finance